Maura Gillison, Who Transformed the Treatment of Mouth and Throat Cancers, Dies at 61
The oncology community mourns the death of Maura Gillison, a doctor who transformed the treatment of mouth and throat cancers.
📍 The outcome
Maura Gillison died at age 61. She was recognized by ASCO and others for transforming the treatment of mouth and throat cancers.
Epilogue added 92d ago, after coverage quieted.
The obvious questions
How old was Maura Gillison at the time of her death?
She was 61.
What specific medical fields did Maura Gillison impact?
She transformed the treatment of mouth and throat cancers.
Which medical organization acknowledged her loss?
The American Society of Clinical Oncology (ASCO).
The story so far
- Velocity & Diffusion: Coverage escalated across 4 distinct news outlets with 4 published articles, achieving a live velocity of 2.
- Primary Driver: The oncology community mourns the death of Maura Gillison, a doctor who transformed the treatment of mouth and throat cancers.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
Maura Gillison has died at the age of 61. She was recognized for her work in transforming the treatment of mouth and throat cancers.
Coverage from the Wall Street Journal and Magzter emphasizes her impact on cancer treatment, while Oncodaily reports that the American Society of Clinical Oncology (ASCO) joined the community in mourning her loss. Reports from The Times of India highlight the growing link between HPV and head and neck cancers, noting that the virus does not only cause cervical cancer.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 93d ago.
Who reported it (4)
-
-
-
-
Maura Gillison, Who Transformed the Treatment of Mouth and Throat Cancers, Dies at 61 WSJ · 96d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
People, places & organizations
Topics
Related trends
CRISPR makes prostate cancer vulnerable to immunotherapy
New CRISPR gene-editing research indicates a method to improve the immune system's ability to detect and target prostate cancer tumors.
Colorectal cancer is on the rise — and often overlooked
Medical experts and patient accounts highlight an increasing prevalence of early-onset colorectal cancer and the risks associated with missed symptoms.
New antibody drug stops aggressive prostate cancer from spreading
8 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Creatine supplements may help halt cancer growth, study suggests
Scientific research into the impact of creatine supplementation on cancer development is sparking conflicting reports regarding its potential risks and benefits.
Leading oncologist reveals 6 habits that could promote longevity and reduce your risk of chronic illness
A leading oncologist is challenging traditional wellness norms by promoting six habits for longevity, including the surprising inclusion of ice cream.
Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.